Impact BioMedical, which is developing a portfolio of consumer wellness and biomedical products, raised $4.5 million by offering 1.5 million shares at $3, the low end of the range of $3 to $5. The pre-revenue company had originally filed in 2023 to sell 2.0...read more
Impact BioMedical, which is developing a portfolio of biomedical technologies, lowered the proposed deal size for its upcoming IPO on Tuesday. In its latest filing, the company also replaced sole bookrunner Aegis Capital with Revere Securities. The Houston,...read more
Impact BioMedical, which is developing a portfolio of biomedical technologies, announced terms for its IPO on Wednesday. The Houston, TX-based company plans to raise $8 million by offering 2 million shares at a price range of $3 to $5. At the midpoint of the...read more
Impact BioMedical, which is developing a portfolio of biomedical technologies, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. Operating mainly through subsidiary Global BioLife, the company funds the research and...read more
Consumer wellness product developer Impact BioMedical prices IPO at $3 low end
Impact BioMedical, which is developing a portfolio of consumer wellness and biomedical products, raised $4.5 million by offering 1.5 million shares at $3, the low end of the range of $3 to $5. The pre-revenue company had originally filed in 2023 to sell 2.0...read more
Biomedical tech developer Impact BioMedical lowers share offering, changes lead bank ahead of $6 million IPO
Impact BioMedical, which is developing a portfolio of biomedical technologies, lowered the proposed deal size for its upcoming IPO on Tuesday. In its latest filing, the company also replaced sole bookrunner Aegis Capital with Revere Securities. The Houston,...read more
Biomedical technology developer Impact BioMedical sets terms for $8 million IPO
Impact BioMedical, which is developing a portfolio of biomedical technologies, announced terms for its IPO on Wednesday. The Houston, TX-based company plans to raise $8 million by offering 2 million shares at a price range of $3 to $5. At the midpoint of the...read more
Biomedical technology developer Impact BioMedical files for a $15 million IPO
Impact BioMedical, which is developing a portfolio of biomedical technologies, filed on Tuesday with the SEC to raise up to $15 million in an initial public offering. Operating mainly through subsidiary Global BioLife, the company funds the research and...read more